verapamil and ursodeoxycholic acid

verapamil has been researched along with ursodeoxycholic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bouscarel, B; Ceryak, S; Fromm, H1
Di, L; Dong, Y; Li, J; Xia, Y; Zhao, X1

Reviews

1 review(s) available for verapamil and ursodeoxycholic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for verapamil and ursodeoxycholic acid

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Comparative effect of ursodeoxycholic acid and calcium antagonists on the binding, uptake and degradation of LDL in isolated hamster hepatocytes.
    Biochimica et biophysica acta, 1996, Jun-11, Volume: 1301, Issue:3

    Topics: Animals; Calcium Channel Blockers; Cricetinae; Diltiazem; Iodine Radioisotopes; Lipoproteins, LDL; Liver; Male; Mesocricetus; Methylation; Nifedipine; Ursodeoxycholic Acid; Verapamil

1996
Transport mechanism of ursodeoxycholic acid in human placental BeWo cells.
    Biopharmaceutics & drug disposition, 2018, Volume: 39, Issue:7

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Cell Line; Cell Survival; Cholagogues and Choleretics; Diketopiperazines; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Neoplasm Proteins; Nitrogen; Placenta; Pregnancy; Ursodeoxycholic Acid; Verapamil

2018